Valuation: Mesa Laboratories, Inc.

Market Cap 547M 481M 448M 412M 773M 52.47B 783M 5.32B 2.08B 25.9B 2.05B 2.01B 89.58B P/E 2027 *
71.9x
P/E 2028 * 45.6x
Enterprise Value 547M 481M 448M 412M 773M 52.47B 783M 5.32B 2.08B 25.9B 2.05B 2.01B 89.58B EV / Sales 2027 *
2.11x
EV / Sales 2028 * 2.01x
Free-Float
94.59%
Yield 2027 *
0.65%
Yield 2028 * 0.65%
1 day+0.28%
1 week-0.17%
Current month-1.79%
1 month-4.54%
3 months-0.19%
6 months+19.64%
Current year+24.55%
1 week 94.1
Extreme 94.1
102.52
1 month 90
Extreme 90
107.68
Current year 71.06
Extreme 71.065
113.99
1 year 55.45
Extreme 55.45
113.99
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 12/04/2026
Director of Finance/CFO 58 29/10/2012
Comptroller/Controller/Auditor 41 01/01/2022
Director TitleAgeSince
Chairman 73 01/09/2017
Director/Board Member 58 04/03/2019
Director/Board Member 57 11/05/2020
Date Insider Type Main position Quantity % Market Cap.
22/6/26 Sell

Chief Financial Officer

-2,827 0.0512%
22/6/26 Sell

Controller/Auditor

-442 0.0080%
22/6/26 Sell

Executive/Senior Manager

-2,516 0.0455%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%-0.17%+29.29%-26.49% 546M
+1.39%+3.78%-17.43%-8.41% 180B
+1.21%+1.23%-9.38%-6.84% 107B
+0.41%+1.06%+7.16%+65.76% 60.29B
+0.67%-1.94%+27.88%+55.85% 50.19B
+1.64%+0.47%-14.25%-43.80% 43.08B
+2.45%-0.23% - - 32.77B
+2.56%-4.28%-17.55%-43.86% 27.61B
+0.93%-7.53%+25.71%-12.70% 23.1B
+2.02%+0.26%-5.23%-5.81% 20.86B
Average +1.36%-2.06%+2.91%-2.92% 54.45B
Weighted average by Cap. +1.33%-0.40%-5.66%+1.96%

Financials

2027 *2028 *
Net sales 259M 228M 212M 195M 366M 24.85B 371M 2.52B 985M 12.27B 973M 952M 42.43B 272M 239M 223M 205M 384M 26.1B 389M 2.64B 1.03B 12.88B 1.02B 1B 44.56B
Net income 7.57M 6.66M 6.2M 5.69M 10.69M 726M 10.83M 73.53M 28.75M 358M 28.4M 27.79M 1.24B 12.13M 10.67M 9.94M 9.13M 17.13M 1.16B 17.36M 118M 46.11M 574M 45.55M 44.56M 1.99B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
27/07/26 USD 97.77 +0.28% 92,259
24/07/26 USD 97.50 -3.42% 120,894
23/07/26 USD 100.95 +2.41% 166,556
22/07/26 USD 98.57 +1.09% 134,820
21/07/26 USD 97.51 +0.87% 116,535
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
97.50USD
Average target price
112.00USD
Spread / Average Target
+14.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock